MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijantimicag.2025.107563

Медицинская библиотека · International journal of antimicrobial agents · 2025

Spanish nationwide survey of Pseudomonas aeruginosa cefiderocol susceptibility and resistance mechanisms.

Sastre-Femenia Miquel Àngel, Fernández-Muñoz Almudena, Gomis-Font María Antonia, Taltavull Biel, López-Causapé Carla, Arca-Suárez Jorge, Martínez-Martínez Luis, Cantón Rafael, Larrosa Nieves, Oteo-Iglesias Jesús, Oliver Antonio, GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Cefiderocol is a new siderophore-cephalosporin showing potent activity against Pseudomonas aeruginosa, including isolates showing extensively drug-resistant (XDR) or difficult-to-treat resistant (DTR) phenotypes. However, there is still a limited understanding of the potential resistance mechanisms. The objective of this study was to analyse the activity of cefiderocol in a nationwide Spanish survey, determine its stability against most relevant resistance mechanisms, and analyse potential drivers of resistance through whole-genome sequencing.

METHODS

Cefiderocol MICs were determined by broth microdilution in cation-adjusted iron-depleted Müller-Hinton broth for 1735 isolates from 66 Spanish hospitals and compared with those of a panel of 13 antipseudomonal agents. All XDR/DTR strains and those resistant to ceftolozane/tazobactam, ceftazidime/avibactam, imipenem/relebactam or cefiderocol were subjected to whole-genome sequencing (NovaSeq, Illumina, San Diego, California, US) and bioinformatic analysis, including specific pipelines developed for the assessment of acquired resistance determinants, the mutational resistome and iron-uptake genes.

RESULTS

Cefiderocol showed the highest percentage of susceptibility (99.7%) and conserved activity (<5-10% resistance) against XDR/DTR strains and those producing carbapenemases. Only five resistant isolates were detected and the complex resistome included acquired β-lactamases or AmpC mutations along with mutations in iron-uptake systems and AmpC and/or efflux pump regulators. Novel drivers of resistance such as piuE were identified. Moreover, the production of acquired oxacillinases and mutations in ampC, mexR or piuA were statistically associated with increased MICs, whereas mutations in gyrA, parC or pvdS were associated with increased susceptibility.

CONCLUSION

While cefiderocol shows potent activity against P. aeruginosa, active surveillance at the phenotypic and genomic level for the emergence of resistant strains should be implemented.

Для цитирования: Sastre-Femenia Miquel Àngel, Fernández-Muñoz Almudena, Gomis-Font María Antonia, Taltavull Biel, López-Causapé Carla, Arca-Suárez Jorge, Martínez-Martínez Luis, Cantón Rafael, Larrosa Nieves, Oteo-Iglesias Jesús, Oliver Antonio, GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group. Spanish nationwide survey of Pseudomonas aeruginosa cefiderocol susceptibility and resistance mechanisms.. International journal of antimicrobial agents. 2025. DOI: 10.1016/j.ijantimicag.2025.107563.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.